While genetic predisposition plays a role in IPF, not all individuals with risk factors develop the disease. Understanding both susceptibility and resilience can provide critical insights into early detection and potential therapeutic strategies. This workshop will explore the latest advancements in genetics, familial risk factors, and emerging research on protective mechanisms that could inform new treatment approaches.

Get ready to explore:

Understanding Resiliency: Why Do Some Individuals Avoid IPF Despite Risk Factors?

• Exploring why some high-risk individuals never develop lung disease
• Identifying protective biological mechanisms that could inform new therapies
• Reviewing emerging research on cellular and molecular markers of resilience

Genetics & Familial Risk Factors: Improving Early Detection

• Investigating hereditary risk factors and genetic polymorphisms in IPF
• Leveraging familial studies and at-risk cohort screenings for early diagnosis
• Exploring predictive modeling and polygenic risk scores Beyond Known Genetics: Novel Research & Therapeutic Targets
• Examining new genetic discoveries beyond well-known mutations
• Understanding gene-environment interactions and epigenetics in IPF
• Exploring industry efforts in gene-targeted therapies and prevention